Successful triple-antibiotic therapy for cutaneous infection due to Mycobacterium chelonae

Clinical Infectious Diseases

Volumn 28, Issue 1, 1999, Pages 145-146

  Jongevos, S Fridolijn ^a   Prens, Errol P ^a   Habets, J M Werner ^a  

^a Ziekenhuis Walcheren   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; DOXYCYCLINE; ETHAMBUTOL; OFLOXACIN; RIFABUTIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; ERYTHEMA; FEMALE; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; PRIORITY JOURNAL; SKIN BIOPSY; SKIN INFECTION; SUBCUTANEOUS NODULE;

EID: 0033031416     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517181     Document Type: Article

References (10)

1. Hirschel B. Infections due to nontuberculous mycobacteria. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, eds. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998:1019-23.
2. Tebas P, Sultan F, Wallace RJ Jr, Fraser V. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis 1995;20:443-4.
3. Saluya A, Peters NT, Lowe L, Johnson T. A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. Int Dermatol Surg 1997;23:539-43.
4. Brown BA, Wallace RJ Jr, Onyi GO, de Rosas V, Wallace RJ. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae and M. chelonae like organisms. Antimicrob Agents Chemother 1992;36:180-4.
5. Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993;119:482-6.
6. Engelhardt Feldmann R, Skaria A, Salomon D. Postoperative infection with Mycobacterium chelonae. Hautarzt 1996;47:863-6.
7. Driscoll MS, Tyring SK. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol 1997;36:495-6.
8. Wallace RJ Jr, Meier A, Brown BA, Zhang Y, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996;40:1676-81.
9. Klemens SP, Di Stefano MS, Cynamon MM. Therapy of multidrug resistant tuberculosis: lessons from studies with mice. Antimicrob Agents Chemother 1993;37:2344-7.
10. Gevaudan MJ, Bollet C, de Micco P. Evaluation of the extra and intra cellular activity of clarithromycin against mycobacterium chelonae. Pathol Biol 1994;42:412-8.